DIASORIN

Research DIASORIN (34D) with Bullrun company financials, valuation charts, model signals, and historical stock context.

Key Metrics

• Ticker34D
• ExchangeDU
• CountryItaly
• CurrencyEUR
• Financial periodFY2025
• RevenueEUR 1.20B
• Revenue growth0.8%
• Net incomeEUR 150.04M
• Free cash flowEUR 281.03M
• Gross margin64.7%

About DIASORIN

General Information and Consolidation Area General information The Diasorin Group specializes in the development, production, and commercialization of immunodiagnostic and molecular diagnostic tests. The Società Capogruppo Diasorin S.p.A. is headquartered at Via Crescentino snc, Saluggia (VC). The Board of Directors on March 20, 2026, authorized the publication of this Consolidated Financial Statement.

Frequently asked questions

What does DIASORIN do?

General Information and Consolidation Area General information The Diasorin Group specializes in the development, production, and commercialization of immunodiagnostic and molecular diagnostic tests. The Società Capogruppo Diasorin S.p.A. is headquartered at Via Crescentino snc, Saluggia (VC).